Literature DB >> 20181141

Healing enhancement of chronic venous stasis ulcers utilizing H-WAVE(R) device therapy: a case series.

Kenneth Blum1, Amanda Lh Chen, Thomas Jh Chen, B William Downs, Eric R Braverman, Mallory Kerner, Stella Savarimuthu, Anish Bajaj, Margaret Madigan, Seth H Blum, Gary Reinl, John Giordano, Nicholas Dinubile.   

Abstract

INTRODUCTION: Approximately 15% (more than 2 million individuals, based on these estimates) of all people with diabetes will develop a lower-extremity ulcer during the course of the disease. Ultimately, between 14% and 20% of patients with lower-extremity diabetic ulcers will require amputation of the affected limb. Analysis of the 1995 Medicare claims revealed that lower-extremity ulcer care accounted for $1.45 billion in Medicare costs. Therapies that promote rapid and complete healing and reduce the need for expensive surgical procedures would impact these costs substantially. One such example is the electrotherapeutic modality utilizing the H-Wave(R) device therapy and program.It has been recently shown in acute animal experiments that the H-Wave(R) device stimulation induces a nitric oxide-dependent increase in microcirculation of the rat Cremaster skeletal muscle. Moreover, chronic H-wave(R) device stimulation of rat hind limbs not only increases blood flow but induces measured angiogenesis. Coupling these findings strongly suggests that H-Wave(R) device stimulation promotes rapid and complete healing without need of expensive surgical procedures. CASE
PRESENTATION: We decided to do a preliminary evaluation of the H-Wave(R) device therapy and program in three seriously afflicted diabetic patients. Patient 1 had chronic venous stasis for 6 years. Patient 2 had chronic recurrent leg ulcerations. Patient 3 had a chronic venous stasis ulcer for 2 years. All were dispensed a home H-Wave(R) unit. Patient 1 had no other treatment, patient 2 had H-Wave(R) therapy along with traditional compressive therapy, and patient 3 had no other therapy.For patient 1, following treatment the ulcer completely healed with the H-Wave(R) device and program after 3 months. For patient 2, by one month complete ulcer closure occurred. Patient 3 had a completely healed ulcer after 9 months.
CONCLUSIONS: While most diabetic ulcers can be treated successfully on an outpatient basis, a significant proportion will persist and become infected. Based on this preliminary case series investigation we found that three patients prescribed H-Wave(R) home treatment demonstrate accelerated healing with excellent results. While these results are encouraging, additional large scale investigation is warranted before any interpretation is given to these interesting outcomes.

Entities:  

Year:  2010        PMID: 20181141      PMCID: PMC2831833          DOI: 10.1186/1757-1626-3-54

Source DB:  PubMed          Journal:  Cases J        ISSN: 1757-1626


  14 in total

1.  Managing venous and neuropathic ulcers.

Authors:  Karen Zulkowski; Catherine R Ratliff
Journal:  Nursing       Date:  2004-08

2.  Diagnosis and treatment of diabetic foot infections.

Authors:  Benjamin A Lipsky; Anthony R Berendt; H Gunner Deery; John M Embil; Warren S Joseph; Adolf W Karchmer; Jack L LeFrock; Daniel P Lew; Jon T Mader; Carl Norden; James S Tan
Journal:  Plast Reconstr Surg       Date:  2006-06       Impact factor: 4.730

3.  Endostatin down-regulates soluble guanylate cyclase (sGC) in endothelial cells in vivo: influence of endostatin on vascular endothelial growth factor (VEGF) signaling.

Authors:  Annette Schmidt; Daniela Wenzel; Irmgard Thorey; Sabine Werner; Bernd K Fleischmann; Wilhelm Bloch
Journal:  Endothelium       Date:  2005 Sep-Dec

4.  Patient with diabetes and venous stasis ulcers.

Authors:  G McNeil; D Paduano
Journal:  J Wound Ostomy Continence Nurs       Date:  1996-11       Impact factor: 1.741

5.  Development of a content-validated venous ulcer guideline.

Authors:  Laura Bolton; Lisa Corbett; Laurie Bernato; Peggy Dotson; Scott Laraus; Diane Merkle; Gregory Patterson; Tania Phillips; Patrick McNees; Peggy Porter Riedesel; Peter Sheehan
Journal:  Ostomy Wound Manage       Date:  2006-11       Impact factor: 2.629

6.  Expression of nitric oxide synthase isoforms and arginase in normal human skin and chronic venous leg ulcers.

Authors:  S A Abd-El-Aleem; M W Ferguson; I Appleton; S Kairsingh; E B Jude; K Jones; C N McCollum; G W Ireland
Journal:  J Pathol       Date:  2000-08       Impact factor: 7.996

Review 7.  Incorporating wound healing strategies to improve palliation (symptom management) in patients with chronic wounds.

Authors:  Oscar M Alvarez; Cathy Kalinski; Jeanne Nusbaum; Luz Hernandez; Emanuel Pappous; Charles Kyriannis; Rachelle Parker; Gail Chrzanowski; Christopher P Comfort
Journal:  J Palliat Med       Date:  2007-10       Impact factor: 2.947

8.  Does the proximity of an amputation, length of time between foot ulcer development and amputation, or glycemic control at the time of amputation affect the mortality rate of people with diabetes who undergo an amputation?

Authors:  Richard N Jones; William P Marshall
Journal:  Adv Skin Wound Care       Date:  2008-03       Impact factor: 2.347

9.  Differential analyses of angiogenesis and expression of growth factors in micro- and macrovascular endothelial cells of type 2 diabetic rats.

Authors:  X H Wang; S F Chen; H M Jin; R M Hu
Journal:  Life Sci       Date:  2008-12-16       Impact factor: 5.037

Review 10.  Understanding eNOS for pharmacological modulation of endothelial function: a translational view.

Authors:  Branko Braam; Marianne C Verhaar
Journal:  Curr Pharm Des       Date:  2007       Impact factor: 3.116

View more
  2 in total

1.  Insurance Companies Fighting the Peer Review Empire without any Validity: the Case for Addiction and Pain Modalities in the face of an American Drug Epidemic.

Authors:  K Blum; W Jacobs; E J Modestino; N DiNubile; D Baron; T McLaughlin; D Siwicki; I Elman; M Moran; E R Braverman; P K Thanos; R D Badgaiyan
Journal:  SEJ Surg Pain       Date:  2018-10-04

2.  Hypothesizing in the Face of the Opioid Crisis Coupling Genetic Addiction Risk Severity (GARS) Testing with Electrotherapeutic Nonopioid Modalities Such as H-Wave Could Attenuate Both Pain and Hedonic Addictive Behaviors.

Authors:  Ashim Gupta; Abdalla Bowirrat; Luis Llanos Gomez; David Baron; Igor Elman; John Giordano; Rehan Jalali; Rajendra D Badgaiyan; Edward J Modestino; Mark S Gold; Eric R Braverman; Anish Bajaj; Kenneth Blum
Journal:  Int J Environ Res Public Health       Date:  2022-01-04       Impact factor: 3.390

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.